HomeIMRX • NASDAQ
Immuneering Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.56M | 13.84% |
Net income | -18.05M | -19.68% |
Net profit margin | — | — |
Earnings per share | -0.58 | -11.54% |
EBITDA | -18.46M | -13.95% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.14M | -57.81% |
Total assets | 52.71M | -48.61% |
Total liabilities | 11.33M | -5.66% |
Total equity | 41.39M | — |
Shares outstanding | 31.05M | — |
Price to book | 0.94 | — |
Return on assets | -76.51% | — |
Return on capital | -86.31% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -18.05M | -19.68% |
Cash from operations | -14.51M | -23.23% |
Cash from investing | 5.49M | 75.26% |
Cash from financing | -40.99K | -623.14% |
Net change in cash | -9.06M | -4.94% |
Free cash flow | -9.79M | -20.58% |
Previous close
$1.25
Day range
$1.13 - $1.28
Year range
$1.00 - $3.83
Market cap
41.27M USD
Avg Volume
174.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Website
Employees
66
